Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

WHO backs use of untested drugs in Ebola

Public health risk means it is ethical to offer treatments with unknown adverse effects

- PMLiVE

Pfizer to work with genetics firm on bowel disease

Agrees deal with 23andMe to research ulcerative colitis and Crohn’s disease

- PMLiVE

UK pharmacies can play bigger public health role

Report says pharmacies should extend range of services for communities

- PMLiVE

Handle with care: patient-centric market research

Working with patients to gather insight aimed at transforming brand communications can be a delicate business

- PMLiVE

Medivir names new CEO

Niklas Prager has experience at Merck & Co and Pfizer

- PMLiVE

GSK relaunches COPD website

Revamped online hub offers tools and guidance for those affected by respiratory condition

Exploring MINT: Part 2 – Indonesia

In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...

Inizio

- PMLiVE

Boehringer planning job cuts in Germany

German newspapers reveals pharma company plans to reduce costs to be able to invest

- PMLiVE

Walgreens to complete takeover of Alliance Boots

Creates global leader in pharmacy

Novartis building

Novartis will file heart failure drug before year-end

New data reinforces view that LCZ696 can reduce cardiovascular deaths

Pharma deals during July 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for July 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links